Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 1:31 AM
Ignite Modification Date:
2025-12-25 @ 1:31 AM
NCT ID:
NCT01271894
Eligibility Criteria:
All participants enrolled into the main Encore1 study at participating sub-study sites will be eligible to participate.
Participants must meet the following additional inclusion criteria prior to intensive pharmacokinetic assessment. Inclusion Criteria:
* provide written sub-study consent at or before week 0
* taken randomized study drugs for at least 4 weeks but less than 8 weeks
* taken EFV in the evening for at least 7 days
* taken all EFV doses over the 3 preceding days.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
16 Years
Study:
NCT01271894
Study Brief:
Protocol Section:
NCT01271894